Clinical Results of Vaccine Therapy for Cancer: Learning from History for Improving the Future
- 1 January 2006
- book chapter
- Published by Elsevier in Advances in Cancer Research
- Vol. 95, 147-202
- https://doi.org/10.1016/s0065-230x(06)95005-2
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- In vitro preparation and functional assessment of human monocyte-derived dendritic cells—potential antigen-specific modulators of in vivo immune responsesTransplant Immunology, 2005
- Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamideBlood, 2005
- Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanomaHuman Immunology, 2004
- Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating FactorClinical Cancer Research, 2004
- DNA fusion gene vaccines against cancer: from the laboratory to the clinicImmunological Reviews, 2004
- Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®Seminars in Cancer Biology, 2003
- CancerVax, An Allogeneic Tumor Cell Vaccine, Induces Specific Humoral and Cellular Immune Responses in Advanced Colon CancerAnnals of Surgical Oncology, 2001
- Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaInternational Journal of Cancer, 1999
- Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastasesCancer, 1999
- Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialThe Lancet, 1999